125,500.00
-300(-0.24%)
Currency In KRW
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
566
First IPO Date
June 23, 2016
| Name | Title | Pay | Year Born |
| Geun-Jo Im | Chief Executive Officer & Director | 0 | 1959 |
| Kyeong Eun Jung | Senior MD & GM of Oligo Research Department | 0 | 1961 |
| Kyeong-Jin Kim | Research Director & Inside Director | 0 | 1963 |
| Dong-Ryul Lee | Head of Management Support Division & Inside Director | 0 | 1968 |
| Jung-Young Seok | MD & Chief of Quality Assurance Office | 0 | 1961 |
| Seok-Woo Choi | MD & GM of Sales 1st Department | 0 | 1968 |
| Soon-Gi Jang | MD & Banwol 1st Factory Mang. | 0 | 1968 |
ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.